Epic Sciences

Epic Sciences

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.epicsciences.com

Last Round

Series G

Apr 14, 2023

Total Funding Raised

$204.5M

Momentum Score

50 /100

Company Overview

Epic Sciences is a biotechnology company specializing in diagnostic tests technology for the rapid and non-invasive detection of genetic and molecular changes in cancer.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Clinical Trials, Biotechnology, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

liquid biopsycancer diagnosticscirculating tumor cellsCTCcell-free DNAcfDNAtherapy selectionmulti-analyte analysisprecision oncologycompanion diagnosticsclinical trial supportmetastatic breast cancermetastatic prostate cancermachine learning diagnosticscomprehensive cancer profilingDefineMBCOncotype DX AR-V7 Nucleus Detect

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Epic Sciences Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Epic Sciences Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series GApr 14, 2023
Series FJun 2, 2022
Series ESep 12, 2018
Series DApr 28, 2017
Series CJul 30, 2014
Series B
Nov 13, 2012

Key People

Founding team and executive leadership

Jason Christiansen

Chief Technology Officer

Executive Team

Epic Sciences Investors

Notable investors and investment history

InvestorRounds
RusnanoMedInvestSeries C
Deerfield ManagementSeries E, Series F, Series G
Genomic HealthSeries D
Domain AssociatesSeries E, Series G, Series D, Series C, Series B
Domain Partners IXSeries E, Series B, Series D
Altos Capital PartnersSeries E, Series D
RMI PartnersSeries D

Epic Sciences Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Epic Sciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Epic Sciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range39
Year Founded2008
Last FundingApr 14, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.